198 related articles for article (PubMed ID: 27785422)
21. The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma.
Yousef A; Yousef M; Zeineddine M; More A; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine F; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally C; Kee B; Kopetz S; Goldstein D; Uppal A; White MG; Helmink B; Fournier K; Raghav K; Taggart M; Overman MJ; Shen JP
medRxiv; 2023 Sep; ():. PubMed ID: 37745596
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
Brown RW; Campagna LB; Dunn JK; Cagle PT
Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
[TBL] [Abstract][Full Text] [Related]
23. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
[TBL] [Abstract][Full Text] [Related]
24. Stage 0 mucinous adenocarcinoma in situ of the urachus.
Paul AB; Hunt CR; Harney JM; Jenkins JP; McMahon RF
J Clin Pathol; 1998 Jun; 51(6):483-4. PubMed ID: 9771454
[TBL] [Abstract][Full Text] [Related]
25. Abscess of urachal remnants presenting with acute abdomen: a case series.
Tazi F; Ahsaini M; Khalouk A; Mellas S; Stuurman-Wieringa RE; Elfassi MJ; Farih MH
J Med Case Rep; 2012 Jul; 6():226. PubMed ID: 22846644
[TBL] [Abstract][Full Text] [Related]
26. Urachal carcinoma: The journey so far and the road ahead.
Kumar R; Harilal S; Abdelgawad MA; Ghoneim MM; Kumar A; Mathew B
Pathol Res Pract; 2023 Mar; 243():154379. PubMed ID: 36821941
[TBL] [Abstract][Full Text] [Related]
27. Urachal cancer-current concepts of a rare cancer.
Reis H; Szarvas T
Pathologe; 2019 Jun; 40(Suppl 1):31-39. PubMed ID: 30895340
[TBL] [Abstract][Full Text] [Related]
28. Patterns of Urachal Remnant Involvement by Urothelial Carcinoma: Intraluminal Noninvasive Spread Can Mimic a Deep-seated Bladder Invasion.
Han L; Gallan A; Paner GP
Am J Surg Pathol; 2019 Apr; 43(4):475-479. PubMed ID: 30475253
[TBL] [Abstract][Full Text] [Related]
29. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
Bian J; Sun X; Li B; Ming L
Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
[TBL] [Abstract][Full Text] [Related]
30. [Urachal cancer - current concepts of a rare cancer (German version)].
Reis H; Szarvas T
Pathologe; 2018 Dec; 39(Suppl 2):291-300. PubMed ID: 30470871
[TBL] [Abstract][Full Text] [Related]
31. Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.
Zaleski MP; Chen H; Roy-Chowdhuri S; Patel KP; Luthra R; Routbort MJ; Kamat AM; Gao J; Siefker-Radtke A; Czerniak B; Guo CC
Am J Clin Pathol; 2022 Aug; 158(2):263-269. PubMed ID: 35467000
[TBL] [Abstract][Full Text] [Related]
32. A Rare Case of Urachal Sinus.
Sreepadma S; Rao BR; Ratkal J; Kulkarni V; Joshi R
J Clin Diagn Res; 2015 Jul; 9(7):PD01-2. PubMed ID: 26393165
[TBL] [Abstract][Full Text] [Related]
33. Enteric type urachal adenocarcinoma: a case report.
El Demellawy D; Nasr A; Alowami S; Escott N
Can J Urol; 2009 Aug; 16(4):4753-6. PubMed ID: 19671231
[TBL] [Abstract][Full Text] [Related]
34. Surgical treatment of urachal remnants in an adult population-a single-centre experience.
Ryan PC; Kelly C; Afridi I; Fawaz A; Aboelmagd M; Cullen IM; Keane JP; Daly PJ
Ir J Med Sci; 2023 Dec; 192(6):3023-3027. PubMed ID: 36935447
[TBL] [Abstract][Full Text] [Related]
35. Alpha-methylacyl-coenzyme a racemase-expressing urachal adenocarcinoma of the abdominal wall.
Ha YS; Kim YW; Min BD; Lee OJ; Kim YJ; Yun SJ; Lee SC; Kim WJ
Korean J Urol; 2010 Jul; 51(7):498-500. PubMed ID: 20664785
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of 14 cases of urachal carcinoma].
Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL
Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037
[TBL] [Abstract][Full Text] [Related]
37. [Surgical experience with urachal carcinoma].
Martínez-Cornelio A; Flores-López D; Ojeda RF; Quintero-Becerra J; Hernández-Toriz N
Cir Cir; 2009; 77(1):33-8. PubMed ID: 19344561
[TBL] [Abstract][Full Text] [Related]
38. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
Torenbeek R; Lagendijk JH; Van Diest PJ; Bril H; van de Molengraft FJ; Meijer CJ
Histopathology; 1998 Jan; 32(1):20-7. PubMed ID: 9522212
[TBL] [Abstract][Full Text] [Related]
39. Treatment approaches for urachal cancer: Use of immunotherapy and targeted therapies.
Benjamin DJ; Kalebasty AR
Rare Tumors; 2023; 15():20363613231189984. PubMed ID: 37465663
[TBL] [Abstract][Full Text] [Related]
40. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
Wright JL; Porter MP; Li CI; Lange PH; Lin DW
Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
